N/A Completed N=1,349

Efficacy and Tolerability of Xalatan in Patients

Glaucoma · Hypertension

Source: ClinicalTrials.gov NCT00950690 ↗

Enrolled (actual)

1,349

Serious AEs

—

Results posted

Aug 2009

Primary outcomePrimary: Intraocular Pressure

Summary

Efficacy data was not collected or analyzed. This study did assess safety and tolerability of Xalatan.

Outcome Measures

Outcome	Result	p-value
PRIMARY Intraocular Pressure	—	—
PRIMARY Humphrey Perimetry Visual Field	—	—

Eligibility Criteria

Inclusion Criteria

Patient with ocular hypertension at least 22mg Hg
Patient must be over 18 years old

Exclusion Criteria

None listed in the protocol

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00950690). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.